CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The CBTRUS story: providing accurate population-based statistics on brain and other central nervous system tumors for everyone

(2018) Carol Kruchko et al.   NEURO-ONCOLOGY

Females have the survival advantage in glioblastoma

(2018) Quinn T Ostrom et al.   NEURO-ONCOLOGY

Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014

(2018) Quinn T. Ostrom et al.   JAMA Oncology

Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013

(2018) Emily V Walker et al.   NEURO-ONCOLOGY

The whole-genome landscape of medulloblastoma subtypes

(2017) Paul A. Northcott et al.   NATURE

Genomic Insights into Diffuse Intrinsic Pontine Glioma

(2017) Danielle H. Lapin et al.   Frontiers in Oncology

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

(2016) Michele Ceccarelli et al.   CELL

Frontal glioblastoma multiforme may be biologically distinct from non-frontal and multilobar tumors

(2016) Iddo Paldor et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004–2012, varying)

(2016) Quinn T. Ostrom et al.   JOURNAL OF NEURO-ONCOLOGY

Advances in the molecular genetics of gliomas — implications for classification and therapy

(2016) Guido Reifenberger et al.   Nature Reviews Clinical Oncology

Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics

(2016) Lindsey M. Hoffman et al.   Acta Neuropathologica Communications

Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131

(2015) Michael A. Vogelbaum et al.   JOURNAL OF NEURO-ONCOLOGY

Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004–2011

(2015) Ryan L. Lym et al.   JOURNAL OF NEURO-ONCOLOGY

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

(2015) Jeanette E. Eckel-Passow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Brain tumors in Sweden: Data from a population-based registry 1999–2012

(2014) Thomas Asklund et al.   ACTA ONCOLOGICA

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma

(2014) Gang Wu et al.   NATURE GENETICS

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

(2014) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms

(2014) SONGTAO QI et al.   Oncology Letters

Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

(2013) Brenda K. Edwards et al.   CANCER

MGMT-STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951

(2013) M. J. van den Bent et al.   CLINICAL CANCER RESEARCH

Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System

(2013) Leah L. Zullig et al.   MILITARY MEDICINE

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

(2012) Marcel Kool et al.   ACTA NEUROPATHOLOGICA

Predicting US- and state-level cancer counts for the current calendar year

(2012) Li Zhu et al.   CANCER

Molecular subgroups of medulloblastoma

(2012) Paul A Northcott et al.   Expert Review of Neurotherapeutics

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

(2012) Gregory Cairncross et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

(2012) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma

(2011) Jacques Grill et al.   PEDIATRIC BLOOD & CANCER

Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective

(2010) Martin J. van den Bent   ACTA NEUROPATHOLOGICA

Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma

(2010) Houtan Noushmehr et al.   CANCER CELL

The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry

(2009) Adelheid Wöhrer et al.   JOURNAL OF NEURO-ONCOLOGY

Universal sample preparation method for proteome analysis

(2009) Jacek R Wiśniewski et al.   NATURE METHODS

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity

(2008) Monika E. Hegi et al.   JOURNAL OF CLINICAL ONCOLOGY